Glycadia Pharmaceuticals
Phase 1Commitment to Discovery Glycadia is a clinical-stage biopharmaceutical company developing therapeutics for the prevention and treatment of kidney, eye, cardiovascular and related diseases that result from diabetes. Learn More Focus and Market The current approach to
Founded
2018
Focus
Small Molecules
About
Commitment to Discovery Glycadia is a clinical-stage biopharmaceutical company developing therapeutics for the prevention and treatment of kidney, eye, cardiovascular and related diseases that result from diabetes. Learn More Focus and Market The current approach to
Company Info
TypePrivate
Founded2018
LocationSan Diego, United States
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile